Seroquel Paragraph IV Certification Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for AstraZeneca's Seroquel (quetiapine) was filed Aug. 12, according to FDA's Oct. 4 updated list of filings